Condensed Statements of Operations - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Operating expenses:
Research and development	$ 13,575	$ 4,134
General and administrative	3,793	952
Total operating expenses	17,368	5,086
Loss from operations	(17,368)	(5,086)
Other income (expense), net	93	(5)
Net loss	$ (17,275)	$ (5,091)
Net loss per share, basic (in dollars per share)	$ (0.74)	$ (6.36)
Net loss per share, diluted (in dollars per share)	$ (0.74)	$ (6.36)
Weighted average common shares outstanding, basic (in shares)	23,216,206	800,679
Weighted average common shares outstanding, diluted (in shares)	23,216,206	800,679